Rznomics presented Phase 1/2a interim clinical re
Browsing: All news
Category Added in a WPeMatico Campaign
Humacyte presented Phase 3 V012 results at the So
Halia Therapeutics announced that the U.S.
Regeneration Biomedical, Inc.
Elysium Health launched Creatine+, a three-in-one
Fractyl Health reports one-year data suggesting
New peer-reviewed findings suggest tackling two
Following promising results in disease treatment
Agemica founder recognized in King Charles III’s Birthday Honours as his AI-driven longevity platform advances toward in vivo testing. Professor Ronjon Nag, founder and CEO of longevity therapeutics company Agemica, has been appointed an Officer of the Order of the…
New biomarkers, existing drugs and decades of ce